ReachRxResearch
Home
Research
Sign Up
Baseline Deep Capillary Plexus Ischemia Predicts Earlier Diabetic Retinopathy Complications Than Foveal Avascular Enlargement
Back to Research Hub
  1. Home
  2. Research Hub
  3. Baseline Deep Capillary Plexus Ischemia…

Baseline Deep Capillary Plexus Ischemia Predicts Earlier Diabetic Retinopathy Complications Than Foveal Avascular Enlargement

American Journal of Ophthalmology·August 14
OphthalmologyPractice changingDiabetic Macular IschemiaDiabetic RetinopathyProspective Observational Cohort StudyOptical Coherence Tomography AngiographyAdult

Summary

View source

What was studied

This prospective cohort study evaluated whether two OCTA-derived diabetic macular ischemia metrics—deep capillary plexus geometric perfusion deficit (GPDd) and foveal avascular zone enlargement (FAZe)—predicted diabetic retinopathy (DR) complication risk and timing over 2 years in 265 eyes (175 patients) across the DR severity spectrum.

Key findings

Each +1 SD increase in baseline GPDd (3.62%) was associated with a 77% higher hazard of DR complications (p<0.001) and a 70-day shorter complication-free survival (95% CI, −103.9 to −36.0). Eyes with high GPDd developed complications ~4 months earlier than low-GPDd eyes (117.2 days; p=0.001). FAZe was not independently predictive after adjusting for GPDd.

Study limitations

DR severity was excluded from the primary Cox model due to collinearity with OCTA metrics, which may limit confounding adjustment. The 2-year follow-up window may miss later complications. Single-center prospective cohort design limits generalizability.

Clinical implications

Consider quantifying deep capillary plexus GPDd on OCTA at baseline to identify diabetic patients at highest risk for earlier complications—high GPDd eyes may warrant more frequent monitoring intervals. FAZe alone does not add independent prognostic value over GPDd.

Caveats

  • DR severity was excluded from the primary multivariable model due to collinearity with OCTA metrics; residual confounding by DR stage cannot be ruled out.
  • The impact_flag 'practice_changing' is applied cautiously—external validation in multicenter cohorts is needed before widespread clinical adoption.
  • The paper's DOI and publication date are August 2026; as a very recently published study, independent replication has not yet occurred.

Related Questions

Explore related topics

Which OCTA biomarkers best predict diabetic retinopathy progression?How does deep capillary plexus ischemia compare to FAZ metrics in monitoring diabetic macular disease?What follow-up intervals are recommended for high-risk diabetic retinopathy patients on OCTA surveillance?

Publication Details

Year
2026
Journal
American Journal of Ophthalmology
Sample Size
n=265
Source
View article
Keep scrolling
More content below.
Up Next